MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1182/blood.2021015350

Медицинская библиотека · Blood · 2022

Immunothrombosis and vascular heterogeneity in cerebral cavernous malformation.

Globisch Maria A, Onyeogaziri Favour C, Jauhiainen Suvi, Yau Anthony C Y, Orsenigo Fabrizio, Conze Lei L, Arce Maximiliano, Corada Monica, Smith Ross O, Rorsman Charlotte, Sundell Veronica, Fernando Dinesh, Daniel Geoffrey, Mattsson Oscar, Savander Henri, Wanders Alkwin, Rezai Jahromi Behnam, Laakso Aki, Niemelä Mika, Dejana Elisabetta, Magnusson Peetra U

СтатьяПоддержка исследования: вне правительства СШАПеревод в очереди

Аннотация

Cerebral cavernous malformation (CCM) is a neurovascular disease that results in various neurological symptoms. Thrombi have been reported in surgically resected CCM patient biopsies, but the molecular signatures of these thrombi remain elusive. Here, we investigated the kinetics of thrombi formation in CCM and how thrombi affect the vasculature and contribute to cerebral hypoxia. We used RNA sequencing to investigate the transcriptome of mouse brain endothelial cells with an inducible endothelial-specific Ccm3 knock-out (Ccm3-iECKO). We found that Ccm3-deficient brain endothelial cells had a higher expression of genes related to the coagulation cascade and hypoxia when compared with wild-type brain endothelial cells. Immunofluorescent assays identified key molecular signatures of thrombi such as fibrin, von Willebrand factor, and activated platelets in Ccm3-iECKO mice and human CCM biopsies. Notably, we identified polyhedrocytes in Ccm3-iECKO mice and human CCM biopsies and report it for the first time. We also found that the parenchyma surrounding CCM lesions is hypoxic and that more thrombi correlate with higher levels of hypoxia. We created an in vitro model to study CCM pathology and found that human brain endothelial cells deficient for CCM3 expressed elevated levels of plasminogen activator inhibitor-1 and had a redistribution of von Willebrand factor. With transcriptomics, comprehensive imaging, and an in vitro CCM preclinical model, this study provides experimental evidence that genes and proteins related to the coagulation cascade affect the brain vasculature and promote neurological side effects such as hypoxia in CCMs. This study supports the concept that antithrombotic therapy may be beneficial for patients with CCM.

Для цитирования: Globisch Maria A, Onyeogaziri Favour C, Jauhiainen Suvi, Yau Anthony C Y, Orsenigo Fabrizio, Conze Lei L, Arce Maximiliano, Corada Monica, Smith Ross O, Rorsman Charlotte, Sundell Veronica, Fernando Dinesh, Daniel Geoffrey, Mattsson Oscar, Savander Henri, Wanders Alkwin, Rezai Jahromi Behnam, Laakso Aki, Niemelä Mika, Dejana Elisabetta, Magnusson Peetra U. Immunothrombosis and vascular heterogeneity in cerebral cavernous malformation.. Blood. 2022. DOI: 10.1182/blood.2021015350.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.